Hyperlipidemia and tissue contents of N epsilon-(carboxymethyl)lysine in streptozotocin diabetes.
Niwa
T
T
Nagoya University Branch Hospital, Japan.
Katsuzaki
T
T
Tatemichi
N
N
Takei
Y
Y
D000818:Animals; D000911:Antibodies, Monoclonal; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006949:Hyperlipidemias / Q000150:complications*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008239:Lysine / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood
D000911:Antibodies, Monoclonal; D017127:Glycation End Products, Advanced; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; C048496:N(6)-carboxymethyllysine; D002784:Cholesterol; D003404:Creatinine; D008239:Lysine